| (210) | Number of the EPO application | 19876025 |
| (220) | Filing date of the EPO application | 2019.08.02 |
| (80) | EPO patent specification publication (B) | EPB nr. 18/2023, 2023.05.03 |
| (110) | EPO patent number | 3830092 |
| (21) | Number of the application | e 2021 0538 |
| (71) | Name(s) of applicant(s), code of the country | NOVARTIS AG, CH; |
| (72) | Name(s) of inventor(s), code of the country | VOLKMANN Robert A., US;
ANDERSON David R., US;
MALEKIANI Sam, US;
PISER Timothy, US;
KEANEY Gregg F., US;
LEISER Steven C., US; |
| (73) | Name(s) of owner(s), code of the country | NOVARTIS AG, CH; |
| (54) | Title of the invention | HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); A61P 25/18 (2006.01.01) |
| (19) | Country | CH |
| (41) | Date of publication of the application | 2021.07.31 |
| (30) | Priority | 201862714100 P, 2018.08.03, US |
| (86) | International application | PCT/US2019/044814, 2019.08.02 |
| (87) | International publication | WO 2020/086136, 2020.04.30 |